Nuvation Bio , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in ...

ICSE board has released the official syllabus for classes 9 to 12 to help students prepare for the board exams. Students can ...

Eli Lilly and Astellas will be the lead bidders at an auction for Sangamo assets. Elsewhere, an investor syndicate committed $230 million to a gene editing startup and Merck KGaA struck a ...

ESPN NFL draft analyst Matt Miller said Tuesday that he was in a vehicle crash and had to have his left arm amputated. “Last ...

The hematopoietic stem cell transplantation market is experiencing steady growth, driven by the rising prevalence of ...

aDivision of Neurology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada bCenter for Neuroinflammation and Experimental Therapeutics and Division of multiple ...

U.S. bio company Life Biosciences announced on the 9th (local time) that it has begun clinical trials applying its so-called “age reversal” technology, which rejuvenates cells, to humans for the first ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) and reminds investors of the ...

CHICAGO (WGN) — Illinois Gov. JB Pritzker says he will sign a bill limiting students’ access to cell phones during class after it passed the Senate on Sunday. Senate Bill 2427 requires schools to set ...

Primaries will be held on Aug. 6. Caroline SolerPolling researcher Republicans are entering the 2026 midterms with a 217-212 majority in the House, with five seats currently vacant and one independent ...

The MarketWatch News Department was not involved in the creation of this content. -- First--in--class DARKFOX--targeting bispecific T cell engager: ENA101 is designed to selectively recognize the ...